中华皮肤科杂志 ›› 2025, Vol. 58 ›› Issue (3): 197-208.doi: 10.35541/cjd.20240547
中国研究型医院学会皮肤科学专业委员会 中国医师协会皮肤科医师分会
收稿日期:2024-10-16
修回日期:2025-01-09
发布日期:2025-03-07
通讯作者:
陈崑；鲁严；顾恒
E-mail:kunchen181@aliyun.com; luyan6289@163.com; guheng@aliyun.com
Dermatology Professional Committee of Chinese Research Hospital Society; China Dermatologist Association
Received:2024-10-16
Revised:2025-01-09
Published:2025-03-07
Contact:
Chen Kun; Lu Yan; Gu Heng
E-mail:kunchen181@aliyun.com; luyan6289@163.com; guheng@aliyun.com
摘要： 【摘要】 紫外线光疗是治疗白癜风的重要措施之一，为指导和规范紫外线光疗在白癜风治疗中的应用，提高疗效和安全性，中国研究型医院学会皮肤科学专业委员会、中国医师协会皮肤科医师分会组织国内光医学及色素疾病领域专家，依据近年来国内外白癜风光疗最新研究进展及专家临床经验，经充分讨论，制订了《白癜风光疗指南（2025版）》，对白癜风紫外线光疗的原理、禁忌证、个体化光疗方案、联合治疗及不良反应等临床实践中重点关注的内容提出了指导意见，以进一步提升我国白癜风治疗水平。
中国研究型医院学会皮肤科学专业委员会 中国医师协会皮肤科医师分会. [开放获取] 白癜风光疗指南（2025版）[J]. 中华皮肤科杂志, 2025,58(3):197-208. doi:10.35541/cjd.20240547
Dermatology Professional Committee of Chinese Research Hospital Society, China Dermatologist Association. Guideline on phototherapy for vitiligo （2025 edition）[J]. Chinese Journal of Dermatology, 2025, 58(3): 197-208.doi:10.35541/cjd.20240547
| ［1］ | Bergqvist C, Ezzedine K. Vitiligo: a focus on pathogenesis and its therapeutic implications［J］. J Dermatol, 2021,48（3）:252⁃270. doi: 10.1111/1346⁃8138.15743. |
| ［2］ | Bae JM, Jung HM, Hong BY, et al. Phototherapy for vitiligo: a systematic review and meta⁃analysis［J］. JAMA Dermatol, 2017,153（7）:666⁃674. doi: 10.1001/jamadermatol.2017.0002. |
| ［3］ | 康德英, 许能锋. 循证医学［M］. 3版. 北京: 人民卫生出版社, 2015:51⁃52. |
| ［4］ | Li Y, Zhang RZ. Mobilization of melanocytes during NB⁃UVB treatment of vitiligo［J］. Int J Dermatol Venereol, 2021,4（3）:163⁃167. doi: 10.1097/JD9.0000000000000128. |
| ［5］ | Vieyra⁃Garcia PA, Wolf P. A deep dive into UV⁃based phototherapy: mechanisms of action and emerging molecular targets in inflammation and cancer［J］. Pharmacol Ther, 2021,222:107784. doi: 10.1016/j.pharmthera.2020.107784. |
| ［6］ | Yamada T, Hasegawa S, Inoue Y, et al. Wnt/β⁃catenin and kit signaling sequentially regulate melanocyte stem cell differentiation in UVB⁃induced epidermal pigmentation［J］. J Invest Dermatol, 2013,133（12）:2753⁃2762. doi: 10.1038/jid. 2013.235. |
| ［7］ | Tembhre MK, Sharma VK, Sharma A, et al. T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo［J］. Clin Chim Acta, 2013,424:27⁃32. doi: 10.1016/j.cca.2013.05.005. |
| ［8］ | Wu CS, Yu CL, Wu CS, et al. Narrow⁃band ultraviolet⁃B stimulates proliferation and migration of cultured melanocytes［J］. Exp Dermatol, 2004,13（12）:755⁃763. doi: 10.1111/j.0906⁃6705.2004.00221.x. |
| ［9］ | Moretti S, Fabbri P, Baroni G, et al. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis［J］. Histol Histopathol, 2009,24（7）:849⁃857. doi: 10.14670/HH⁃24.849. |
| ［10］ | Sharma CK, Sharma M, Prasad K. Involvement of different genes expressions during immunological and inflammatory responses in vitiligo［J］. Crit Rev Eukaryot Gene Expr, 2017,27（3）:277⁃287. doi: 10.1615/CritRevEukaryotGeneExpr.2017019558. |
| ［11］ | Jung EG. The red face: photogenodermatoses［J］. Clin Dermatol, 1993,11（2）:275⁃281. doi: 10.1016/0738⁃081x（93）90063⁃i. |
| ［12］ | Goulden V, Ling TC, Babakinejad P, et al. British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022［J］. Br J Dermatol, 2022,187（3）:295⁃308. doi: 10.1111/bjd.21669. |
| ［13］ | 中国医师协会皮肤科医师分会规范化诊疗工作委员会, 中国医学装备协会皮肤病与皮肤美容专业委员会皮肤外科装备学组和皮肤光治疗学组. 窄谱中波紫外线家庭光疗临床应用专家共识［J］. 中华皮肤科杂志, 2019,52（3）:156⁃161. doi: 10.3760/cma.j.issn.0412⁃4030.2019.03.002. |
| ［14］ | Dahir AM, Thomsen SF. Comorbidities in vitiligo: comprehensive review［J］. Int J Dermatol, 2018,57（10）:1157⁃1164. doi: 10.1111/ ijd.14055. |
| ［15］ | Lee JH, Ju HJ, Seo JM, et al. Comorbidities in patients with vitiligo: a systematic review and meta⁃analysis［J］. J Invest Dermatol, 2023,143（5）:777⁃789.e6. doi: 10.1016/j.jid.2022.10. 021. |
| ［16］ | Premkumar M, Kalarani IB, Mohammed V, et al. An extensive review of vitiligo⁃associated conditions［J］. Int J Dermatol Venerol, 2024,7（1）:44⁃51. doi: 10.1097/JD9.0000000000000346. |
| ［17］ | Esmat SM, El⁃Mofty M, Rasheed H, et al. Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo⁃types （III⁃V）: a double⁃blind, randomized, placebo⁃controlled, prospective, multicenter study［J］. Photodermatol Photoimmunol Photomed, 2022,38（3）:277⁃287. doi: 10.1111/phpp.12749. |
| ［18］ | Kanwar AJ, Dogra S, Parsad D, et al. Narrow⁃band UVB for the treatment of vitiligo: an emerging effective and well⁃tolerated therapy［J］. Int J Dermatol, 2005,44（1）:57⁃60. doi: 10.1111/j.1365⁃4632.2004.02329.x. |
| ［19］ | Bhatnagar A, Kanwar AJ, Parsad D, et al. Psoralen and ultraviolet A and narrow⁃band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study［J］. J Eur Acad Dermatol Venereol, 2007,21（10）:1381⁃1385. doi: 10.1111/j.1468⁃3083.2007.02283.x. |
| ［20］ | Majid I, Imran S. Excimer light therapy in childhood segmental vitiligo: early treatment gives better results［J］. Dermatol Ther, 2020,33（3）:e13408. doi: 10.1111/dth.13408. |
| ［21］ | Do JE, Shin JY, Kim DY, et al. The effect of 308 nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo［J］. Photodermatol Photoimmunol Photomed, 2011,27（3）:147⁃151. doi: 10.1111/j.1600⁃0781.2011.00587.x. |
| ［22］ | Ezzedine K, Lim HW, Suzuki T, et al. Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference［J］. Pigment Cell Melanoma Res, 2012,25（3）:E1⁃13. doi: 10.1111/j.1755⁃148X.2012.00997.x. |
| ［23］ | 中国中西医结合学会皮肤性病专业委员会色素病学组. 白癜风诊疗共识（2021版）［J］. 中华皮肤科杂志, 2021,54（2）:105⁃109. doi: 10.35541/cjd.20200785. |
| ［24］ | Lommerts JE, Uitentuis SE, Bekkenk MW, et al. The role of phototherapy in the surgical treatment of vitiligo: a systematic review［J］. J Eur Acad Dermatol Venereol, 2018,32（9）:1427⁃1435. doi: 10.1111/jdv.14950. |
| ［25］ | Choi KH, Park JH, Ro YS. Treatment of vitiligo with 308⁃nm xenon⁃chloride excimer laser: therapeutic efficacy of different initial doses according to treatment areas［J］. J Dermatol, 2004,31（4）:284⁃292. doi: 10.1111/j.1346⁃8138.2004.tb00674.x. |
| ［26］ | Alhowaish AK, Dietrich N, Onder M, et al. Effectiveness of a 308⁃nm excimer laser in treatment of vitiligo: a review［J］. Lasers Med Sci, 2013,28（3）:1035⁃1041. doi: 10.1007/s10103⁃012⁃1185⁃1. |
| ［27］ | Bae JM, Hann SK. Laser treatments for vitiligo［J］. Med Lasers, 2016,5（2）:63⁃70. doi:10.25289/ML.2016.5. 2.63. |
| ［28］ | Mohammad TF, Al⁃Jamal M, Hamzavi IH, et al. The Vitiligo Working Group recommendations for narrowband ultraviolet B light phototherapy treatment of vitiligo［J］. J Am Acad Dermatol, 2017,76（5）:879⁃888. doi: 10.1016/j.jaad.2016.12.041. |
| ［29］ | Hofer A, Hassan AS, Legat FJ, et al. Optimal weekly frequency of 308⁃nm excimer laser treatment in vitiligo patients［J］. Br J Dermatol, 2005,152（5）:981⁃985. doi: 10.1111/j.1365⁃2133.2004. 06321.x. |
| ［30］ | Seneschal J, Speeckaert R, Taïeb A, et al. Worldwide expert recommendations for the diagnosis and management of vitiligo: position statement from the international Vitiligo Task Force⁃Part 2: specific treatment recommendations［J］. J Eur Acad Dermatol Venereol, 2023,37（11）:2185⁃2195. doi: 10.1111/jdv. 19450. |
| ［31］ | Nicolaidou E, Antoniou C, Stratigos AJ, et al. Efficacy, predictors of response, and long⁃term follow⁃up in patients with vitiligo treated with narrowband UVB phototherapy［J］. J Am Acad Dermatol, 2007,56（2）:274⁃278. doi: 10.1016/j.jaad.2006. 09.004. |
| ［32］ | Errichetti E, Zelin E, Pinzani C, et al. Dermoscopic and clinical response predictor factors in nonsegmental vitiligo treated with narrowband ultraviolet B phototherapy: a prospective observational study［J］. Dermatol Ther （Heidelb）, 2020,10（5）:1089⁃1098. doi: 10.1007/s13555⁃020⁃00431⁃6. |
| ［33］ | van Geel N, Speeckaert R, De Wolf J, et al. Clinical significance of Koebner phenomenon in vitiligo［J］. Br J Dermatol, 2012,167（5）:1017⁃1024. doi: 10.1111/j.1365⁃2133.2012.11158.x. |
| ［34］ | Hojman L, Cabrera R, Karsulovic C, et al. The role of CXCL10 and IL⁃18 as markers of repigmentation response in nonsegmental vitiligo treated with narrowband UVB phototherapy: a prospective Cohort study［J］. J Invest Dermatol, 2021,141（7）:1833⁃1836.e1. doi: 10.1016/j.jid.2020.12.021. |
| ［35］ | Parihar AS, Tembhre MK, Sharma VK, et al. Effect of narrowband ultraviolet B treatment on microRNA expression in active nonsegmental generalized vitiligo［J］. Br J Dermatol, 2020,183（1）:167⁃169. doi: 10.1111/bjd.18890. |
| ［36］ | Monib K, Sabry HH, Hussein MS, et al. Factors affecting vitiligo response to treatment: do MiRNA 196a2C/T gene polymorphism and serum tyrosinase levels have any role?［J］. J Dermatolog Treat, 2022,33（3）:1351⁃1355. doi: 10.1080/09546634.2020.181 0202. |
| ［37］ | Lin F, Sun X, Lei J, et al. Altered circulating memory T cells in vitiligo cases followed NB⁃UVB therapy［J］. Photodermatol Photoimmunol Photomed, 2022,38（1）:76⁃82. doi: 10.1111/phpp. 12719. |
| ［38］ | Salem RM, Abdelrahman A, Abd El⁃Kareem HM, et al. DEFB1 gene polymorphisms modify vitiligo extent and response to NB⁃UVB phototherapy［J］. Dermatol Ther, 2021,34（3）:e14921. doi: 10.1111/dth.14921. |
| ［39］ | Monib K, Sorour NE, Alhusseini NF, et al. Could α MSH⁃MIFT axis and IDH2 be considered promising predictors of non⁃segmental vitiligo response to NB⁃UVB phototherapy?［J］. J Clin Aesthet Dermatol, 2023,16（1）:41⁃46. |
| ［40］ | Parsad D, Pandhi R, Dogra S, et al. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches［J］. J Am Acad Dermatol, 2004,50（1）:63⁃67. doi: 10.1016/s0190⁃9622（03）00786⁃2. |
| ［41］ | Lei TC, Hearing VJ. Deciphering skin re⁃pigmentation patterns in vitiligo: an update on the cellular and molecular events involved［J］. Chin Med J （Engl）, 2020,133（10）:1231⁃1238. doi: 10.1097/CM9.0000000000000794. |
| ［42］ | Silpa⁃Archa N, Weerasubpong P, Junsuwan N, et al. Treatment outcome and persistence of repigmentation from narrow⁃band ultraviolet B phototherapy in vitiligo［J］. J Dermatolog Treat, 2019,30（7）:691⁃696. doi: 10.1080/09546634.2018.1544409. |
| ［43］ | 贺楷乔, 李舒丽, 李柏樟, 等. 白癜风光疗复色模式的临床观察及其影响因素分析［J］. 中华皮肤科杂志, 2024,57（1）:23⁃28. doi:10.35541/cjd.20230367. |
| ［44］ | Lopes C, Trevisani VF, Melnik T. Efficacy and safety of 308⁃nm monochromatic excimer lamp versus other phototherapy devices for vitiligo: a systematic review with meta⁃analysis［J］. Am J Clin Dermatol, 2016,17（1）:23⁃32. doi: 10.1007/s40257⁃015⁃0164⁃2. |
| ［45］ | Tabassum H, Majid I, Imran S. Is targeted UVB as effective as excimer light phototherapy in treatment of vitiligo?［J］. Dermatol Ther, 2021,34（5）:e15058. doi: 10.1111/dth.15058. |
| ［46］ | Poolsuwan P, Churee C, Pattamadilok B. Comparative efficacy between localized 308⁃nm excimer light and targeted 311⁃nm narrowband ultraviolet B phototherapy in vitiligo: a randomized, single⁃blind comparison study［J］. Photodermatol Photoimmunol Photomed, 2021,37（2）:123⁃130. doi: 10.1111/phpp.12619. |
| ［47］ | Yadav D, Khandpur S, Bhari N. Targeted phototherapy with excimer light is not efficacious in the management of residual vitiligo patches following whole⁃body narrowband ultraviolet B light therapy: results of a retrospective case series［J］. Indian J Dermatol Venereol Leprol, 2022,88（2）:249⁃251. doi: 10.25259/IJDVL_8_2020. |
| ［48］ | Le Duff F, Fontas E, Giacchero D, et al. 308⁃nm excimer lamp vs. 308⁃nm excimer laser for treating vitiligo: a randomized study［J］. Br J Dermatol, 2010,163（1）:188⁃192. doi: 10.1111/j.1365⁃2133.2010.09778.x. |
| ［49］ | Hu Y, Liu L, Xu Z, et al. Comparing the efficacy of 308⁃nm light⁃emitting diode and 308⁃nm excimer lamp for treating vitiligo: a randomized controlled trial［J］. Photodermatol Photoimmunol Photomed, 2024,40（3）:e12972. doi: 10.1111/phpp.12972. |
| ［50］ | Luan C, Hu Y, Ju M, et al. Treatment of vitiligo with 308⁃nm light emitting diode: our experience from a two⁃year follow⁃up of Chinese patients［J］. Photodermatol Photoimmunol Photomed, 2022,38（5）:489⁃494. doi: 10.1111/phpp.12777. |
| ［51］ | Teasdale E, Muller I, Abdullah Sani A, et al. Views and experiences of seeking information and help for vitiligo: a qualitative study of written accounts［J］. BMJ Open, 2018,8（1）:e018652. doi: 10.1136/bmjopen⁃2017⁃018652. |
| ［52］ | Tien Guan ST, Theng C, Chang A. Randomized, parallel group trial comparing home⁃based phototherapy with institution⁃based 308 excimer lamp for the treatment of focal vitiligo vulgaris［J］. J Am Acad Dermatol, 2015,72（4）:733⁃735. doi: 10.1016/j.jaad. 2014.12.026. |
| ［53］ | Liu B, Sun Y, Song J, et al. Home vs hospital narrowband UVB treatment by a hand⁃held unit for new⁃onset vitiligo: a pilot randomized controlled study［J］. Photodermatol Photoimmunol Photomed, 2020,36（1）:14⁃20. doi: 10.1111/phpp.12495. |
| ［54］ | DePry J, Brescoll J, Szczotka⁃Flynn L, et al. Phototherapy⁃related ophthalmologic disorders［J］. Clin Dermatol, 2015,33（2）:247⁃255. doi: 10.1016/j.clindermatol.2014.10.017. |
| ［55］ | Prystowsky JH, Keen MS, Rabinowitz AD, et al. Present status of eyelid phototherapy. Clinical efficacy and transmittance of ultraviolet and visible radiation through human eyelids［J］. J Am Acad Dermatol, 1992,26（4）:607⁃613. doi: 10.1016/0190⁃9622（92）70089⁃x. |
| ［56］ | Giblin FJ, Lin LR, Leverenz VR, et al. A class I （Senofilcon A） soft contact lens prevents UVB⁃induced ocular effects, including cataract, in the rabbit in vivo［J］. Invest Ophthalmol Vis Sci, 2011,52（6）:3667⁃3675. doi: 10.1167/iovs.10⁃6885. |
| ［57］ | Giblin FJ, Lin LR, Simpanya MF, et al. A class I UV⁃blocking （senofilcon A） soft contact lens prevents UVA⁃induced yellow fluorescence and NADH loss in the rabbit lens nucleus in vivo［J］. Exp Eye Res, 2012,102:17⁃27. doi: 10.1016/j.exer.2012.06. 007. |
| ［58］ | Stern RS, Bagheri S, Nichols K, et al. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A （PUVA） for psoriasis［J］. J Am Acad Dermatol, 2002,47（1）:33⁃39. doi: 10.1067/mjd.2002.124618. |
| ［59］ | Stern RS. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation （PUVA） and ultraviolet B radiation. The photochemotherapy follow⁃up study［J］. N Engl J Med, 1990,322（16）:1093⁃1097. doi: 10.1056/NEJM199004193 221601. |
| ［60］ | Deshpande AJ. 308 nm excimer lamp monotherapy for lip vitiligo⁃a short case series［J］. J Cosmet Laser Ther, 2020,22（6⁃8）:253⁃255. doi: 10.1080/14764172.2021.1936065. |
| ［61］ | Cho S, Zheng Z, Park YK, et al. The 308⁃nm excimer laser: a promising device for the treatment of childhood vitiligo［J］. Photodermatol Photoimmunol Photomed, 2011,27（1）:24⁃29. doi: 10.1111/j.1600⁃0781.2010.00558.x. |
| ［62］ | Ersoy⁃Evans S, Altaykan A, Sahin S, et al. Phototherapy in childhood［J］. Pediatr Dermatol, 2008,25（6）:599⁃605. doi: 10.1111/j.1525⁃1470.2008.00773.x. |
| ［63］ | Eustace K, Dolman S, Alsharqi A, et al. Use of phototherapy in children［J］. Pediatr Dermatol, 2017,34（2）:150⁃155. doi: 10. 1111/pde.13072. |
| ［64］ | Bangsgaard N, Rørbye C, Skov L. Treating psoriasis during pregnancy: safety and efficacy of treatments［J］. Am J Clin Dermatol, 2015,16（5）:389⁃398. doi: 10.1007/s40257⁃015⁃0137⁃5. |
| ［65］ | AlJasser MI. Dermoscopy for facial leukotrichia in vitiligo: an important step for a better treatment decision［J］. Dermatol Pract Concept, 2022,12（3）:e2022114. doi: 10.5826/dpc.1203a114. |
| ［66］ | Mogawer RM, Elmasry MF, Mostafa WZ. New insights into leukotrichia in nonsegmental vitiligo: a cross⁃sectional study［J］. Indian J Dermatol Venereol Leprol, 2019,85（4）:374⁃379. doi: 10.4103/ijdvl.IJDVL_49_18. |
| ［67］ | Lee DY, Kim CR, Park JH, et al. The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment［J］. Int J Dermatol, 2011,50（8）:925⁃927. doi: 10. 1111/j.1365⁃4632.2011.04914.x. |
| ［68］ | Lei N, Cao X, Feng Y, et al. A novel reverse perilesional home phototherapy can promote the repigmentation of vitiligo patches with complete leukotrichia: a 12⁃week, open⁃label, double⁃arm, multicenter, randomized clinical trial［J］. Photodermatol Photoimmunol Photomed, 2024,40（3）:e12974. doi: 10.1111/phpp.12974. |
| ［69］ | Zhu B, Liu C, Zhang L, et al. Comparison of NB⁃UVB combination therapy regimens for vitiligo: a systematic review and network meta⁃analysis［J］. J Cosmet Dermatol, 2023,22（3）:1083⁃1098. doi: 10.1111/jocd.15534. |
| ［70］ | Li R, Qiao M, Wang X, et al. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta⁃analysis［J］. Photodermatol Photoimmunol Photomed, 2017,33（1）:22⁃31. doi: 10.1111/phpp.12277. |
| ［71］ | Lee J, Chu H, Lee H, et al. A retrospective study of methylprednisolone mini⁃pulse therapy combined with narrow⁃band UVB in non⁃segmental vitiligo［J］. Dermatology, 2016,232（2）:224⁃229. doi: 10.1159/000439563. |
| ［72］ | Thomas KS, Batchelor JM, Akram P, et al. Randomized controlled trial of topical corticosteroid and home⁃based narrowband ultraviolet B for active and limited vitiligo: results of the HI⁃Light Vitiligo Trial［J］. Br J Dermatol, 2021,184（5）:828⁃839. doi: 10.1111/bjd.19592. |
| ［73］ | Fang WC, Lin SY, Huang SM, et al. Low⁃dose tofacitinib with 308⁃nm excimer therapy successfully induced repigmentation in patients with refractory vitiligo［J］. Clin Exp Dermatol, 2022,47（4）:782⁃783. doi: 10.1111/ced.15070. |
| ［74］ | Song H, Hu Z, Zhang S, et al. Effectiveness and safety of tofacitinib combined with narrowband ultraviolet B phototherapy for patients with refractory vitiligo in real⁃world clinical practice［J］. Dermatol Ther, 2022,35（11）:e15821. doi: 10.1111/dth.15821. |
| ［75］ | Liu LY, Strassner JP, Refat MA, et al. Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure［J］. J Am Acad Dermatol, 2017,77（4）:675⁃682.e1. doi: 10.1016/j.jaad.2017.05.043. |
| ［76］ | Xu Z, Xuan Y, Li Y, et al. A prospective observational study of oral abrocitinib and narrow⁃band ultraviolet⁃B in refractory progressive vitiligo［J］. J Am Acad Dermatol, 2024,91（3）:590⁃592. doi: 10.1016/j.jaad.2024.05.078. |
| ［77］ | Sheikh A, Rafique W, Owais R, et al. FDA approves ruxolitinib （Opzelura） for vitiligo therapy: a breakthrough in the field of dermatology［J］. Ann Med Surg （Lond）, 2022,81:104499. doi: 10.1016/j.amsu.2022.104499. |
| ［78］ | Pandya AG, Harris JE, Lebwohl M, et al. Addition of narrow⁃band UVB phototherapy to ruxolitinib cream in patients with vitiligo［J］. J Invest Dermatol, 2022,142（12）:3352⁃3355.e4. doi: 10.1016/j.jid.2022.05.1093. |
| ［79］ | Phan K, Phan S, Shumack S, et al. Repigmentation in vitiligo using janus kinase （JAK） inhibitors with phototherapy: systematic review and meta⁃analysis［J］. J Dermatolog Treat, 2022,33（1）:173⁃177. doi: 10.1080/09546634.2020.1735615. |
| ［80］ | Hu M, Liao K, Lei W, et al. The addition of topical calcipotriol to phototherapy enhance the efficacy of treatment in patients with vitiligo: a systematic review and meta⁃analysis［J］. Int Immunopharmacol, 2021,98:107910. doi: 10.1016/j.intimp.2021. 107910. |
| ［81］ | Liu X, Yao Z, Wang Y, et al. Vitamin D analogs combined with different types of phototherapy in the treatment of vitiligo: a systematic review of randomized trials and within⁃patient studies［J］. Int Immunopharmacol, 2022,109:108789. doi: 10.1016/j.intimp.2022.108789. |
| ［82］ | Juntongjin P, Sangganjanavanich P. Efficacy of the combined excimer light and topical calcipotriol for acral vitiligo: a randomized double⁃blind comparative study［J］. Dermatol Ther, 2021,34（2）:e14886. doi: 10.1111/dth.14886. |
| ［83］ | Arora CJ, Rafiq M, Shumack S, et al. The efficacy and safety of tacrolimus as mono⁃ and adjunctive therapy for vitiligo: a systematic review of randomised clinical trials［J］. Australas J Dermatol, 2020,61（1）:e1⁃e9. doi: 10.1111/ajd.13096. |
| ［84］ | Bae JM, Hong BY, Lee JH, et al. The efficacy of 308⁃nm excimer laser/light （EL） and topical agent combination therapy versus EL monotherapy for vitiligo: a systematic review and meta⁃analysis of randomized controlled trials （RCTs）［J］. J Am Acad Dermatol, 2016,74（5）:907⁃915. doi: 10.1016/j.jaad.2015.11.044. |
| ［85］ | Dang YP, Li Q, Shi F, et al. Effect of topical calcineurin inhibitors as monotherapy or combined with phototherapy for vitiligo treatment: a meta⁃analysis［J］. Dermatol Ther, 2016,29（2）:126⁃133. doi: 10.1111/dth.12295. |
| ［86］ | Lee JH, Kwon HS, Jung HM, et al. Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta⁃analysis［J］. JAMA Dermatol, 2019,155（8）:929⁃938. doi: 10.1001/jamadermatol.2019.0696. |
| ［87］ | Ju HJ, Han JH, Kim MS, et al. The long⁃term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo［J］. J Am Acad Dermatol, 2021,84（6）:1619⁃1627. doi: 10.1016/j.jaad.2021.01.067. |
| ［88］ | Nordal EJ, Guleng GE, Rönnevig JR. Treatment of vitiligo with narrowband⁃UVB （TL01） combined with tacrolimus ointment （0.1%） vs. placebo ointment, a randomized right/left double⁃blind comparative study［J］. J Eur Acad Dermatol Venereol, 2011,25（12）:1440⁃1443. doi: 10.1111/j.1468⁃3083.2011.04002.x. |
| ［89］ | Zhang DM, Hong WS, Fu LF, et al. A randomized controlled study of the effects of different modalities of narrow⁃band ultraviolet B therapy on the outcome of cultured autologous melanocytes transplantation in treating vitiligo［J］. Dermatol Surg, 2014,40（4）:420⁃426. doi: 10.1111/dsu.12444. |
| ［90］ | 王美玲, 王保强, 刘华绪. CO2点阵激光联合308 nm准分子激光治疗白癜风疗效和安全性meta分析［J］. 中国麻风皮肤病杂志, 2021,37（1）:13⁃18. |
| ［91］ | Kim WI, Kim S, Lee SH, et al. The efficacy of fractional carbon dioxide laser combined with narrow⁃band ultraviolet B phototherapy for non⁃segmental vitiligo: a systematic review and meta⁃analysis［J］. Lasers Med Sci, 2021,36（1）:165⁃173. doi: 10.1007/s10103⁃020⁃03069⁃0. |
| ［92］ | Chang HC, Lin MH, Tsai HH. Efficacy of combination therapy with fractional carbon dioxide laser and ultraviolet B phototherapy for vitiligo: a systematic review and meta⁃analysis［J］. Aesthet Surg J, 2020,40（1）:NP46⁃NP50. doi: 10.1093/asj/sjz250. |
| ［93］ | Esmat S, Assaf MI, Mohye Eldeen R, et al. Evaluation of needling/microneedling as an adjunct to phototherapy in the treatment of stable acral vitiligo: a comparative clinical and immunohistochemical study［J］. J Dermatolog Treat, 2022,33（5）:2621⁃2628. doi: 10.1080/09546634.2022.2062279. |
| ［94］ | Chu GY, Weng SM, Huang CC, et al. Surrounding needling and narrowband ultraviolet B phototherapy treatment: synergistic effects for repigmentation in chronic, stable nonsegmental vitiligo［J］. Altern Ther Health Med, 2023,29（1）:96⁃103. |
| ［95］ | Jung HM, Jung YS, Lee JH, et al. Antioxidant supplements in combination with phototherapy for vitiligo: a systematic review and metaanalysis of randomized controlled trials［J］. J Am Acad Dermatol, 2021,85（2）:506⁃508. doi: 10.1016/j.jaad.2018.10.010. |
| ［96］ | Middelkamp⁃Hup MA, Bos JD, Rius⁃Diaz F, et al. Treatment of vitiligo vulgaris with narrow⁃band UVB and oral polypodium leucotomos extract: a randomized double⁃blind placebo⁃controlled study［J］. J Eur Acad Dermatol Venereol, 2007,21（7）:942⁃950. doi: 10.1111/j.1468⁃3083.2006.02132.x. |
| ［97］ | Fontas E, Montaudié H, Passeron T. Oral gliadin⁃protected superoxide dismutase in addition to phototherapy for treating non⁃segmental vitiligo: a 24⁃week prospective randomized placebo⁃controlled study［J］. J Eur Acad Dermatol Venereol, 2021,35（8）:1725⁃1729. doi: 10.1111/jdv.17331. |
| ［98］ | Dell'Anna ML, Mastrofrancesco A, Sala R, et al. Antioxidants and narrow band⁃UVB in the treatment of vitiligo: a double⁃blind placebo controlled trial［J］. Clin Exp Dermatol, 2007,32（6）:631⁃636. doi: 10.1111/j.1365⁃2230.2007.02514.x. |
| ［99］ | Sun Y, Guan X, Wang H, et al. Randomized clinical trial of combined therapy with oral α⁃lipoic acid and NB⁃UVB for nonsegmental stable vitiligo［J］. Dermatol Ther, 2021,34（1）:e14610. doi: 10.1111/dth.14610. |
| ［100］ | Yones SS, Palmer RA, Garibaldinos TM, et al. Randomized double⁃blind trial of treatment of vitiligo: efficacy of psoralen⁃UV⁃A therapy vs narrowband⁃UV⁃B therapy［J］. Arch Dermatol, 2007,143（5）:578⁃584. doi: 10.1001/archderm.143.5.578. |
| ［101］ | Bhatnagar A, Kanwar AJ, Parsad D, et al. Comparison of systemic PUVA and NB⁃UVB in the treatment of vitiligo: an open prospective study［J］. J Eur Acad Dermatol Venereol, 2007,21（5）:638⁃642. doi: 10.1111/j.1468⁃3083.2006.02035.x. |
| ［102］ | Dincer Rota D, Aksoy Sarac G, Arca E, et al. Comparison of the efficacy of broad⁃band targeted UVB phototherapy and topical psoralen with targeted UVA phototherapy in localized vitiligo［J］. Dermatol Ther, 2021,34（1）:e14562. doi: 10.1111/dth. 14562. |
| ［103］ | Halpern SM, Anstey AV, Dawe RS, et al. Guidelines for topical PUVA: a report of a workshop of the British photodermatology group［J］. Br J Dermatol, 2000,142（1）:22⁃31. doi: 10.1046/j.1365⁃2133.2000.03237.x. |
| ［104］ | Esmat S, Hegazy RA, Shalaby S, et al. Phototherapy and combination therapies for vitiligo［J］. Dermatol Clin, 2017,35（2）:171⁃192. doi: 10.1016/j.det.2016.11.008. |
| ［105］ | Shenoi SD, Prabhu S, Indian Association of Dermatologists VaL, et al. Photochemotherapy （PUVA） in psoriasis and vitiligo［J］. Indian J Dermatol Venereol Leprol, 2014,80（6）:497⁃504. doi: 10.4103/0378⁃6323.144143. |
| ［106］ | El⁃Zawahry BM, Bassiouny DA, Sobhi RM, et al. A comparative study on efficacy of UVA1 vs. narrow⁃band UVB phototherapy in the treatment of vitiligo［J］. Photodermatol Photoimmunol Photomed, 2012,28（2）:84⁃90. doi: 10.1111/j.1600⁃0781.2011. 00643.x. |
| ［107］ | El⁃Zawahry BM, Elmasry MF, Ragab A. The role of long⁃wavelength ultraviolet A1 （UVA1） in acral vitiligo［J］. J Cosmet Dermatol, 2019,18（4）:1155⁃1160. doi: 10.1111/jocd. 12808. |
| ［108］ | Lotti T, Tchernev G, Wollina U, et al. Successful treatment with UVA 1 laser of non ⁃ responder vitiligo patients［J］. Open Access Maced J Med Sci, 2018,6（1）:43⁃45. doi: 10.3889/oamjms.2018.047. |
| ［109］ | Babino G, Giunta A, Esposito M, et al. UVA1 laser in the treatment of vitiligo［J］. Photomed Laser Surg, 2016,34（5）:200⁃204. doi: 10.1089/pho.2015.4004. |
| ［110］ | Zubair R, Hamzavi IH. Phototherapy for vitiligo［J］. Dermatol Clin, 2020,38（1）:55⁃62. doi: 10.1016/j.det.2019.08.005. |
| ［111］ | Barros NM, Sbroglio LL, Buffara MO, et al. Phototherapy［J］. An Bras Dermatol, 2021,96（4）:397⁃407. doi: 10.1016/j.abd. 2021.03.001. |
| ［112］ | Bae JM, Ju HJ, Lee RW, et al. Evaluation for skin cancer and precancer in patients with vitiligo treated with long⁃term narrowband UV⁃B phototherapy［J］. JAMA Dermatol, 2020,156（5）:529⁃537. doi: 10.1001/jamadermatol.2020.0218. |
| ［113］ | Perna JJ, Mannix ML, Rooney JF, et al. Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model［J］. J Am Acad Dermatol, 1987,17（3）:473⁃478. doi: 10.1016/s0190⁃9622（87）70232⁃1. |
| ［114］ | Bae JM, Eun SH, Oh SH, et al. The 308⁃nm excimer laser treatment does not increase the risk of skin cancer in patients with vitiligo: a population⁃based retrospective cohort study［J］. Pigment Cell Melanoma Res, 2019,32（5）:714⁃718. doi: 10. 1111/pcmr.12781. |
| [1] | 袁勇勇 潘萌. 家族性慢性良性天疱疮研究进展[J]. 中华皮肤科杂志, 2025, 0(3): 20240182-e20240182. |
| [2] | 中国康复医学会皮肤病康复专业委员会 中华医学会皮肤性病学分会 中国医学装备协会皮肤病与皮肤美容分会光医学治疗装备学组. [开放获取] 红蓝黄光治疗皮肤病临床应用专家共识（2025版）[J]. 中华皮肤科杂志, 2025, 58(3): 209-215. |
| [3] | 李倩雯 廖志锴 乐悦 段博林 耿朦朦 雷铁池. 抗氧化剂Tempol抑制氧化应激状态下免疫诱导白癜风小鼠尾部皮肤色素脱失[J]. 中华皮肤科杂志, 2025, 58(2): 126-131. |
| [4] | 宋璞 刘宇 郭森 李舒丽 刘玲 李春英. 肥大细胞来源的趋化因子配体5影响氧化应激状态下白癜风CD8+ T细胞的迁移[J]. 中华皮肤科杂志, 2025, 0(2): 20230513-e20230513. |
| [5] | 周妙妮 盛安琪 傅丽芳 金嵘 许文 尉晓冬 许爱娥. 茶多酚抗氧化凝胶联合窄谱中波紫外线治疗白癜风疗效及安全性的单中心随机对照试验[J]. 中华皮肤科杂志, 2025, 0(2): 20240421-e20240421. |
| [6] | 王迪 张瑞珺 康玉英. 脂溢性皮炎的发病机制及治疗研究进展[J]. 中华皮肤科杂志, 2025, 58(1): 89-92. |
| [7] | 罗莉 张博娜 吴畏 汤文静 李岳华 刘晓莉 马雅楠 李翠翠 齐梦岩 孙妮 石琼. [开放获取] 308 nm准分子激光与308 nm准分子光治疗194例儿童白癜风的疗效及安全性回顾分析[J]. 中华皮肤科杂志, 2024, 57(8): 721-727. |
| [8] | 蒋献 刘莲 张婷. 鲜红斑痣的治疗现状及展望[J]. 中华皮肤科杂志, 2024, 57(7): 590-594. |
| [9] | 陈佳希 易秀莉 李春英 李舒丽. 叶酸对体外培养的黑色素细胞氧化应激损伤的保护作用研究[J]. 中华皮肤科杂志, 2024, 57(6): 547-552. |
| [10] | 中华医学会医学美学与美容学分会激光美容学组 中国医学装备协会皮肤病与皮肤美容分会护肤品和护肤材料学组 中国医师协会整形与美容分会激光美容学组 中华医学会皮肤性病学分会美容激光学组 . [开放获取] 化妆品皮肤不良反应诊疗指南（2024版）[J]. 中华皮肤科杂志, 2024, 57(6): 485-492. |
| [11] | 中国医师协会皮肤科医师分会. [开放获取] 慢性瘙痒管理指南（2024版）[J]. 中华皮肤科杂志, 2024, 57(5): 387-399. |
| [12] | 葛新红 马迎东 焦亚宁 刘玲玲 周镁 紫薇 李博文. 532 nm皮秒激光治疗面部早期脂溢性角化病的疗效和安全性分析[J]. 中华皮肤科杂志, 2024, 57(4): 359-362. |
| [13] | 张迪敏 曹成 周妙妮 盛安琪 林福全 许爱娥. 复方倍他米松注射液联合治疗后进展期非节段型白癜风稳定率及影响因素分析[J]. 中华皮肤科杂志, 2024, 57(4): 350-354. |
| [14] | 中华医学会皮肤性病学分会 中国疾病预防控制中心性病控制中心 中国医师协会皮肤科医师分会 中国康复医学会皮肤病康复专业委员会. 中国沙眼衣原体泌尿生殖道感染临床诊疗指南（2024）[J]. 中华皮肤科杂志, 2024, 57(3): 193-200. |
| [15] | 戴叶芹 宋秀祖. 毛囊及毛囊细胞移植在白癜风治疗中的应用进展[J]. 中华皮肤科杂志, 2024, 0(3): 20230274-e0230274. |
|
